Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioXcel Therapeutics, Inc. - Common Stock (NQ:BTAI)

1.820 +0.010 (+0.55%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioXcel Therapeutics, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Dow Up Triple Digits After Bank Stress Test, GDP Revision ↗
The Dow Jones Industrial Average is up 194 points midday, while the S&P 500 Index and Nasdaq Composite move cautiously higher. 
Via Talk Markets
News headline image
Crude Oil Edges Higher; McCormick Posts Upbeat Earnings ↗
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Thursday. The Dow traded up 0.64% to 34,069.87 while the NASDAQ rose 0.13% to 13,609.09. The S&P... 
Via Benzinga
News headline image
Why Shares of BioXcel Therapeutics Are Plunging Thursday ↗
Questions regarding the safety of an Alzheimer's disease agitation therapy were raised when the company announced phase 3 trial results. 
Via The Motley Fool
News headline image
BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Goldman Sachs Maintains Neutral Rating for BioXcel Therapeutics: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Where BioXcel Therapeutics Stands With Analysts ↗
 
Via Benzinga
News headline image
Why Shares of BioXcel Therapeutics Are Dropping Thursday ↗
A trial for one of the company's therapies didn't meet its primary endpoint. 
Via The Motley Fool
News headline image
Why Are BioXcel Therapeutics Shares Plummeting Today ↗
BioXcel Therapeutics Inc (NASDAQ: BTAI) shares are tumbling after the company released topline results for TRANQUILITY II, a Phase 3 trial of BXCL501 for the acute treatment of  
Via Benzinga
News headline image
Dow Rises Over 100 Points; US GDP Grows 2% In Q1 ↗
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.37% to 33,977.04 while the NASDAQ rose... 
Via Benzinga
News headline image
FREY Stock Price Prediction: Is Freyr Battery Really Worth $13? ↗
Freyr Battery (FREY) stock is on the move Thursday with heavy trading following positive coverage from analysts at Morgan Stanley. 
Via InvestorPlace
News headline image
Why Is Cormedix (CRMD) Stock Down 23% Today? ↗
Cormedix (CRMD) stock is falling hard on Thursday with heavy trading after the company priced a public offering of its shares. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Looking Into BioXcel Therapeutics's Return On Capital Employed ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for BioXcel Therapeutics ↗
 
Via Benzinga
News headline image
Why BioXcel Therapeutics Stock Marched Higher Today ↗
The biotech's Q1 earnings report set the stage for a flurry of important clinical updates in the coming months. 
Via The Motley Fool
News headline image
BioXcel Therapeutics's Earnings Outlook ↗
 
Via Benzinga
News headline image
Why Is BioXcel Therapeutics (BTAI) Stock Down 57% Today? ↗
BioXcel Therapeutics (BTAI) stock is taking a beating on Thursday after the company released its latest clinical trial data. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
We're starting Thursday with a detailed look at all of the biggest pre-market stock movers worth keeping an eye on today! 
Via InvestorPlace
News headline image
BioXcel CEO Vimal Mehta Says This Alzheimer's News Is A 'Huge Win For Society' ↗
The company hopes to soon gain approval to treat patients with agitation due to Alzheimer's disease. 
Via Investor's Business Daily
News headline image
3 Short-Squeeze Stocks Set for a Spectacular Gamma Squeeze Rally ↗
If you can’t stand a dull day at the trading desk, these short-squeeze stocks to buy could spike your blood pressure and your portfolio. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Dollar Tree Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Beamr Imaging Ltd. (NASDAQ: BMR) shares climbed 211.6% to $6.86 after NVIDIA announced the release of NVENC Video Codec SDK 12.1 showcasing the integration with Beamr CABR. 
Via Benzinga
News headline image
BioXcel Therapeutics Stock Tumbles: Company Releases Mixed Results From Lower Dose Igalmi Study In Bipolar/Schizophrenia Associated Agitation ↗
 
Via Benzinga
News headline image
BioXcel Stock Crashes 22% As Bid To Double Its Market Appears Less Certain ↗
The company is hoping to double its market opportunity. But that looks less certain. 
Via Investor's Business Daily
News headline image
BioXcel Therapeutics Reports Encouraging Phase 1b Results For Innovative Depression Treatment ↗
BioXcel Therapeutics Inc (NASDAQ: BTAI) announced topline data from its Phase 1b multiple ascending dose (MAD) trial of BXCL501 (dexmedetomidine) sublingual film, for agitation associated with... 
Via Benzinga
News headline image
Why These 3 Nasdaq Stocks Were Glowing Green This Week ↗
These three biopharmaceutical stocks rocketed higher this week. 
Via The Motley Fool
News headline image
BioXcel Earnings Miss Q1 Estimates Due To Higher Costs, Expects Uptick In Revenues ↗
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) reported first-quarter FY23 revenues of $206,000,  
Via Benzinga
News headline image
Axsome Surges As Its Newest Product Shines. But BioXcel Does The Opposite. ↗
Axsome shares are nearing a breakout point. But BioXcel crumbled on its report. 
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.